Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Survival benefit for lenalidomide plus low-dose dexamethasone in multiple myeloma

April 11, 2007

Genta files appeal against FDA decision on Genasense for CLL

April 11, 2007

Novel series of anticancer compounds disclosed in recent patents

April 11, 2007

Ceflatonin studied in new phase II/III study in CML

April 10, 2007

SuperGen completes sale of remaining Nipent rights

April 10, 2007

Tasquinimod enhances response to androgen ablation in prostate cancer models

April 10, 2007

Novel anticancer compounds reported in recent patent literature

April 10, 2007

Pharmacyclics' NDA for Xcytrin to be filed over protest

April 5, 2007

ChemGenex raises funds to support Ceflatonin development program

April 5, 2007

Recent patents impart new therapeutic agents for cancer

April 4, 2007

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...